Cigarette pack size and consumption: a randomized cross-over trial

被引:2
|
作者
Lee, Ilse [1 ]
Blackwell, Anna K. M. [2 ]
Hobson, Alice [1 ,3 ]
Wiggers, Danielle [4 ]
Hammond, David [4 ]
De-Loyde, Katie [2 ]
Pilling, Mark A. [1 ]
Hollands, Gareth J. [1 ,5 ]
Munafo, Marcus R. [2 ]
Marteau, Theresa M. [1 ]
机构
[1] Univ Cambridge, Behav & Hlth Res Unit, Cambridge CB2 0SR, England
[2] Univ Bristol, Sch Psychol Sci, 12a Priory Rd, Bristol, Avon, England
[3] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[4] Univ Waterloo, Fac Hlth, Sch Publ Hlth Sci, Waterloo, ON, Canada
[5] UCL, EPPI Ctr, UCL Social Res Inst, London, England
基金
英国惠康基金;
关键词
cigarettes; Cigarette pack size; randomised cross-over trial; smoking; tobacco control; tobacco control policy; SMOKING; MORTALITY; SMOKERS; ADULTS; NUMBER;
D O I
10.1111/add.16062
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and Aims Smoking fewer cigarettes per day may increase the chances of stopping smoking. Capping the number of cigarettes per pack is a promising policy option, but the causal impact of such a change is unknown. This study aimed to test the hypothesis that lowering cigarette pack sizes from 25 to 20 reduces the number of cigarettes smoked. Design This randomized controlled cross-over trial had two 14-day intervention periods with an intervening 7-day period of usual behaviour. Participants purchased their own cigarettes. They were instructed to smoke their usual brand from either one of two sizes of pack in each of two 14-day intervention periods: (a) 25 cigarettes and (b) 20 cigarettes. Participants were randomized to the order in which they smoked from the two pack sizes (a-b; b-a). Setting Canada. Participants Participants were adult smokers who smoked from pack sizes of 25, recruited between July 2020 and June 2021. Of 252 randomized, 240 (95%) completed the study and 236 (94%) provided sufficient data for the primary analysis. Measurements Cigarettes smoked per participant per day. Findings Participants smoked fewer cigarettes per day from packs of 20 cigarettes [n = 234, mean = 15.7 standard deviation (SD) = 7.1] than from packs of 25 (n = 235, mean = 16.9, SD = 7.1). After adjusting for pre-specified covariates (baseline consumption and heaviness of smoking), modelling estimated that participants smoked 1.3 fewer cigarettes per day [95% confidence interval (CI) = -1.7 to -0.9], equivalent to 7.6% fewer (95% CI = -10.1 to -5.2%) from packs of 20 cigarettes. Conclusions Smoking from packs of 20 compared with 25 cigarettes reduced the number of cigarettes smoked per day.
引用
收藏
页码:489 / 499
页数:11
相关论文
共 50 条
  • [31] Olive Leaf Tea Impact on Postprandial Glycemia: A Randomized Cross-Over Trial
    Meireles, Manuela
    Cortez-Ribeiro, Anna Carolina
    Polck, Denise
    Almeida-de-Souza, Juliana
    Ferro-Lebres, Vera
    FOODS, 2023, 12 (03)
  • [32] Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome
    Rajmohan Dharmaraj
    Pankaj Hari
    Arvind Bagga
    Pediatric Nephrology, 2009, 24 : 775 - 782
  • [33] Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome
    Dharmaraj, Rajmohan
    Hari, Pankaj
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2009, 24 (04) : 775 - 782
  • [34] Arthroscopy or ultrasound in undergraduate anatomy education: a randomized cross-over controlled trial
    Matthias Knobe
    John Bennet Carow
    Miriam Ruesseler
    Benjamin Moritz Leu
    Melanie Simon
    Stefan K Beckers
    Alireza Ghassemi
    Tolga T Sönmez
    Hans-Christoph Pape
    BMC Medical Education, 12
  • [35] Lamotrigine in clozapine-resistant schizophrenia:: A randomized placebocontrolled cross-over trial
    Tiihonen, J
    Hallikainen, T
    Ryynänen, OP
    Tiihonen, ER
    Kotilainen, I
    Eronen, M
    Toivonen, P
    Wahlbeck, K
    Putkonen, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S263 - S263
  • [36] Levels of clinical condom failure for anal sex: A randomized cross-over trial
    Siegler, Aaron J.
    Rosenthal, Elizabeth M.
    Sullivan, Patrick S.
    Mehta, C. Christina
    Moore, Renee H.
    Ahlschlager, Lauren
    Kelley, Colleen F.
    Rosenberg, Eli S.
    Cecil, Michael P.
    ECLINICALMEDICINE, 2019, 17
  • [37] A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome
    Campbell, Kathleen
    Neul, Jeffrey L.
    Lieberman, David N.
    Berry-Kravis, Elizabeth
    Benke, Tim A.
    Fu, Cary
    Percy, Alan
    Suter, Bernhard
    Morris, David
    Carpenter, Randall L.
    Marsh, Eric D.
    von Hehn, Jana
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2025, 17 (01)
  • [38] A randomized cross-over trial of a wedged insole for treatment of knee osteoarthritis.
    Baker, K
    Goggins, J
    Szumowski, K
    Xie, H
    LaValley, M
    Hunter, DJ
    Felson, D
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S459 - S460
  • [39] Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial
    Otto, Marit
    Bach, Flemming W.
    Jensen, Troels S.
    Brosen, Kim
    Sindrup, Soren H.
    PAIN, 2008, 139 (02) : 275 - 283
  • [40] Preliminary results of dapagliflozin in inactive lupus nephritis cross-over randomized trial
    Vajgel, Gisele
    Miranda Filho, Carlos
    Oliveira, Camila
    Costa, Denise Maria
    Silva Junior, Braziliano
    Lima, Camilla
    Sandrin-Garcia, Paula
    Valente, Lucila
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I514 - I514